CD8A and neoplasm: CD8+ T cell cytotoxicity, in turn, is classically believed to depend upon T cell receptor (TCR) recognition of tumor antigens presented exclusively in the context of cell surface major histocompatibility complex (MHC) class I (MHC-I) molecules.